Skip to main content
. 2022 Jul 7;17:2979–2993. doi: 10.2147/IJN.S358138

Figure 7.

Figure 7

In vivo anticancer study of HMMD@PG +L on 4T1-tumor-bearing mice based on intravenous administration. (I) PBS (control group), (II) DOX, (III) HMMD, (IV) HMMD@PG, (V) HMMD@PG + L. (A) Body weight, (B) tumor volume, (C) relative tumor weight and (D) tumor tissue images of 4T1-tumor-bearing mice with different treatments over 14 days. (E) H&E staining images of the dissected tumor tissues and (F) organs after 14 days of treatment. Scale bar: 50 µm. n = 5, *p < 0.05, **p < 0.01, ****p < 0.0001.

Abbreviation: L, laser.